Mereo BioPharma (MREO) Reports In-Line Q2 EPS
Tweet
Share
E-mailGet Alerts MREO Hot Sheet
Join SI Premium – FREE
Mereo BioPharma (NASDAQ: MREO) reported Q2 EPS of ($0.01), in-line with the analyst estimate of ($0.01).
For earnings history and earnings-related data on Mereo BioPharma (MREO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- William Blair Downgrades On Holding AG (ONON) to Market Perform
- Big Sky Industrial Inc. (BSIN) Reports In-Line Q2 EPS
- SpaceXAI launches Grok Bot AI teammates for business tasks
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
